EAElizabeth Anderson

Elizabeth Anderson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Elizabeth Anderson has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • End-of Life Care Disparities Experienced by American Indian and Alaska Natives Peoples: An Analysis of Data from the 2019 Medicare Master Beneficiary Summary File

    by Elizabeth Anderson, R. Turner Goins, Ruqoyat Abdulsalam, Luohua Jiang, Joan O’cOnnell

    Background: American Indian and Alaska Native (AI/AN) adults experience higher rates of chronic diseases and mortality than non-Hispanic White (NHW) adults. Hospice can improve quality of life and reduce hospitalizations for those with terminal illness(es). Aims: To examine hospitalization and hospice use at the end-of-life between AI/AN and NHW patients and the associations of end-of-life hospitalization and hospice use with chronic diseases. Design: Using data extracted from the 2019 Medicare Master Beneficiary Summary File, we estimated regression models to examine our aims among patients who died in 2019. Setting/Participants: Our sample included 6975 AI/AN patients and a 5% sample of 53,465 NHW patients aged ≥65 years. Measurements: Data included patient demographics, health coverage, date of death, diagnosed chronic conditions, hospital inpatient days, and hospice days. The country of study was the United States. Results: AI/AN patients at the end-of-life were more likely to be hospitalized and less likely to use hospice compared with their NHW counterparts. For both AI/AN and NHW patients, having a chronic condition was associated with increased hospital days; having dementia and cancer was associated with more hospice days; while diabetes, cardiovascular disease, chronic kidney disease, end-stage renal disease, and liver disease were associated with fewer hospice days. Conclusions and Relevance: Compared with NHW patients, AI/AN patients received poorer quality end-of-life care. More efforts are needed to understand the barriers and facilitators to hospice for AI/AN patients and in developing strategies that improve access to high-quality end-of-life care for AI/AN patients.


  • Open Access

    Patient-Centered Advance Care Planning in Dialysis

    by Giselle M. Rodriguez de Sosa, Mae Thamer, Elizabeth Anderson, Mark L. Unruh, Dale E. Lupu

    Key Points: Honoring Individuals Goals and Hopes Way: Implementing Advance Care Planning for Persons with Kidney Disease on Dialysis (HIGHWay) empowers dialysis social workers and nurses to lead advance care planning (ACP) discussions with patients as part of their workflow. HIGHWay uses motivational interviewing to overcome barriers in ACP, improve conversation quality, and help engage patients. HIGHWay demonstrated successful adoption, feasibility, and acceptability for ACP practices and outcomes despite barriers in patient readiness and time. Background: Patients on dialysis want to discuss their preferences for treatment. The Shared Decision-Making Renal Supportive Care intervention effectively elicited dialysis patient preferences for end-of-life care. The Honoring Individuals Goals and Hopes Way: Implementing Advance Care Planning for Persons with Kidney Disease on Dialysis (HIGHWay) project updated this intervention to scale it for broader implementation of advance care planning (ACP) to all patients during their regular dialysis sessions, no matter the severity of illness or time on dialysis, and to address previously found barriers. Methods: HIGHWay implemented ACP for dialysis patients of participating social workers and nurses, incorporating these conversations into the regular workflow. Participants completed a 6-hour online training course made by study investigators, focusing on motivational interviewing and person-centered approaches. They then received nine monthly group coaching sessions to strengthen their discussion skills. Data on participant engagement were collected by survey; preprogram, midpoint (6 months), postimplementation (9 months), and weekly surveys were conducted over the following 9 months to track conversations. The Consolidated Framework for Implementation Research framework was used to measure implementation outcomes. Results: We enrolled 55 social workers and nurses from three dialysis organizations from June 2021 to December 2023 across 61 dialysis clinics in the United States. After a 9-month follow-up period, 1526 conversations were conducted. Of these, 868 were newly initiated cases. Participants reported an average of 1.7 conversations per week, most 30 minutes or less. The mean feasibility on 12 ACP-related activities on a 5-point scale increased from 3.4 (SD=1.0) pretraining to 4.2 (SD=0.85) after 9 months of follow-up (P < 0.05). Notably, 65% of the respondents felt more skillful addressing patient reluctance and 60% reported being more at ease with ACP topics. Conclusions: HIGHWay enhances confidence and skills in conducting ACP for patients undergoing chronic dialysis. High scores for acceptability, appropriateness, and sustainability suggest that HIGHWay is ready for widespread use across all US dialysis facilities. Clinical Trial registry name and registration number: NCT05324878. Podcast: This article contains a podcast at https://dts.podtrac.com/redirect.mp3/www.asn-online.org/media/podcast/K360/2025_06_26_KID0000000767.mp3


  • Open Access

    Testing a Culturally Tailored Advance Care Planning Intervention (MY WAY) for an American Indian Tribe: Protocol for a Quasi-Experimental Waitlist Control Design

    by Elizabeth Anderson, R Turner Goins, Emily A Haozous, April Schweinhart

    Background: American Indian and Alaska Native peoples experience poor end-of-life care, including more hospitalizations and lower use of hospice and do-not-resuscitate orders. Although advance care planning (ACP) can improve end-of-life care, ACP rates are disproportionately low in American Indians and Alaska Natives. Objective: We culturally tailored and delivered an existing evidence-based ACP program for an American Indian tribal community. Here, we present the protocol for assessing the intervention’s feasibility and efficacy. Methods: We measured feasibility via participant recruitment, participants’ evaluation (acceptability, appropriateness, comprehension, and satisfaction), and intervention fidelity. Recruitment was measured with participant screening, eligibility, enrollment, and retention. Participant’s evaluation of the intervention was measured with surveys. Fidelity was measured with direct observation and the Make Your Wishes About You (MY WAY) Fidelity Checklist Tool. To assess the intervention’s efficacy, we used a quasi-experimental waitlist control design with 2 cohorts who were surveyed each on three separate occasions. The intervention’s efficacy was assessed by the following: ACP barriers and facilitators as well as ACP self-efficacy, readiness, and completion. Results: A total of 166 participants were screened for eligibility; 11 were deemed ineligible, and 155 participants were enrolled in the study. Of those enrolled, 113 completed the intervention and will be included in subsequent analyses. We finalized data collection in January 2023, and analyses are underway. Study enrollment was successful, and we expect that participants will report high levels of acceptability, appropriateness, comprehension, and satisfaction with the intervention. We expect that the intervention was implemented with fidelity and will demonstrate decreases in ACP barriers and increases in ACP facilitators, self-efficacy, readiness, and completion. Conclusions: Enrolling over twice as many participants as we had hoped suggests that members of this tribal community are willing to engage in end-of-life ACP. We were able to implement a waitlist study design to show that a culturally tailored ACP program for a tribal community is feasible. Trial Registration: ClinicalTrials.gov NCT05304117; https://clinicaltrials.gov/study/NCT05304117 International Registered Report Identifier (IRRID): DERR1-10.2196/50654


  • Open Access

    Testing a Culturally Tailored Advance Care Planning Intervention (MY WAY) for an American Indian Tribe: Protocol for a Quasi-Experimental Waitlist Control Design (Preprint)

    by Elizabeth Anderson, R Turner Goins, Emily A Haozous, April Schweinhart

    BACKGROUND American Indian and Alaska Native peoples experience poor end-of-life care, including more hospitalizations and lower use of hospice and do-not-resuscitate orders. Although advance care planning (ACP) can improve end-of-life care, ACP rates are disproportionately low in American Indians and Alaska Natives. OBJECTIVE We culturally tailored and delivered an existing evidence-based ACP program for an American Indian tribal community. Here, we present the protocol for assessing the intervention’s feasibility and efficacy. METHODS We measured feasibility via participant recruitment, participants’ evaluation (acceptability, appropriateness, comprehension, and satisfaction), and intervention fidelity. Recruitment was measured with participant screening, eligibility, enrollment, and retention. Participant’s evaluation of the intervention was measured with surveys. Fidelity was measured with direct observation and the Make Your Wishes About You (MY WAY) Fidelity Checklist Tool. To assess the intervention’s efficacy, we used a quasi-experimental waitlist control design with 2 cohorts who were surveyed each on three separate occasions. The intervention’s efficacy was assessed by the following: ACP barriers and facilitators as well as ACP self-efficacy, readiness, and completion. RESULTS A total of 166 participants were screened for eligibility; 11 were deemed ineligible, and 155 participants were enrolled in the study. Of those enrolled, 113 completed the intervention and will be included in subsequent analyses. We finalized data collection in January 2023, and analyses are underway. Study enrollment was successful, and we expect that participants will report high levels of acceptability, appropriateness, comprehension, and satisfaction with the intervention. We expect that the intervention was implemented with fidelity and will demonstrate decreases in ACP barriers and increases in ACP facilitators, self-efficacy, readiness, and completion. CONCLUSIONS Enrolling over twice as many participants as we had hoped suggests that members of this tribal community are willing to engage in end-of-life ACP. We were able to implement a waitlist study design to show that a culturally tailored ACP program for a tribal community is feasible. CLINICALTRIAL ClinicalTrials.gov NCT05304117; https://clinicaltrials.gov/study/NCT05304117 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/50654

  • Nephrology and Palliative Care Providers' Beliefs in Engaging American Indian Patients in Palliative Care Conversations

    by Elizabeth Anderson, Caroline Twiggs, R. Turner Goins, Nina Astleford, Blythe Winchester

    Background: American Indians with chronic kidney disease are twice as likely to develop end-stage renal disease. Palliative care is underused by American Indian patients, although studies show it is not due to an unwillingness to engage in conversations about end of life. Objectives: The aim of our study was to explore the experiences and beliefs of Nephrology and palliative care providers of one tribal community with respect to engaging patients and family members in palliative care. Design: Using an interview guide, individual, in-depth interviews were conducted between March and August 2019 with eligible participants. We used constant comparative analysis of interview transcripts. Setting and Subjects: Our study sample included eight participants, including four Nephrology providers and four palliative care providers. Results: We identified five themes, including (1) providers' stereotypes, (2) patients' mistrust of providers, (3) patients' end-of-life preferences, (4) available community resources, and (5) patients' family dynamics. Negative stereotypes were present in every theme, although most participants did not acknowledge the role stereotypes played in establishing trust and building therapeutic relationships conducive to end-of-life discussions. Conclusion: Providers serving American Indian patients with kidney disease should consider training in trauma informed care and cultural sensitivity. Negative stereotypes of American Indian patients may impact provider's ability to build trust, a key component of end-of-life conversations, and contribute to misperceptions related to family dynamics, end-of-life preferences, and available community resources.